We are live on
!
Find out more
TARO
Taro Pharmaceutical Industries Ltd.
TARO
TARO
Delisted
TARO was delisted on the 21st of June, 2024.
114 hedge funds and large institutions have $421M invested in Taro Pharmaceutical Industries Ltd. in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 32 increasing their positions, 31 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
31% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 16
5% more funds holding
Funds holding: 109 → 114 (+5)
3% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 31
16% less capital invested
Capital invested by funds: $500M → $421M (-$78.4M)
Holders
114
Holders Change
+5
Holders Change %
+4.59%
% of All Funds
2.61%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
21
Increased
32
Reduced
31
Closed
16
Calls
$29K
Puts
–
Net Calls
+$29K
Net Calls Change
-$52K
Top Buyers
| 1 |
GC
Globeflex Capital
San Diego,
California
|
+$7.84M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$4.92M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$4.86M |
| 4 |
Renaissance Technologies
New York
|
+$4.76M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$3.02M |
